![The sights of Avalon Air Show 2025: Day Three [PHOTOS]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/03/f-35-avalon-final-day-scaled-e1743079275404.jpg?#)
ATyr hires ex-ChemoCentryx commercial chief for planned launch
ATyr Pharma is stepping up its preparations to launch a steroid-sparing drug with the appointment of a commercial head who previously helped ChemoCentryx communicate a similar value proposition en route to its acquisition by Amgen.
ATyr Pharma is stepping up its preparations to launch a steroid-sparing drug with the appointment of a commercial head who previously helped ChemoCentryx communicate a similar value proposition en route to its acquisition by Amgen.
